Cargando…
Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile
Factor XIIIa (FXIIIa) is a transglutaminase that catalyzes the last step in the coagulation process. Orthostery is the only approach that has been exploited to design FXIIIa inhibitors. Yet, allosteric inhibition of FXIIIa is a paradigm that may offer a key advantage of controlled inhibition over or...
Autores principales: | Al-Horani, Rami A., Karuturi, Rajesh, Lee, Michael, Afosah, Daniel K., Desai, Umesh R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965010/ https://www.ncbi.nlm.nih.gov/pubmed/27467511 http://dx.doi.org/10.1371/journal.pone.0160189 |
Ejemplares similares
-
Synthetic, Non-saccharide, Glycosaminoglycan Mimetics
Selectively Target Colon Cancer Stem Cells
por: Patel, Nirmita J., et al.
Publicado: (2014) -
Homogeneous, Synthetic, Non-Saccharide Glycosaminoglycan Mimetics as Potent Inhibitors of Human Cathepsin G
por: Afosah, Daniel K., et al.
Publicado: (2023) -
Sulphated penta-galloyl glucopyranoside (SPGG) is glycosaminoglycan mimetic allosteric inhibitor of cathepsin G
por: Al-Horani, Rami A, et al.
Publicado: (2023) -
Designing Smaller,
Synthetic, Functional Mimetics
of Sulfated Glycosaminoglycans as Allosteric Modulators of Coagulation
Factors
por: Abdelfadiel, Elsamani I., et al.
Publicado: (2023) -
Designing Synthetic,
Sulfated Glycosaminoglycan Mimetics
That Are Orally Bioavailable and Exhibiting In Vivo Anticancer Activity
por: Morla, Shravan, et al.
Publicado: (2023)